Background: Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. Tumor markers are used to help detect, diagnose, and manage some types of cancer. Although an elevated level of a tumor marker may suggest the presence of cancer. Aim: The aim of this review is to compare and analyze the present and newer oncogenic markers which help in diagnosis of different types of cancers. Material & Methods: An extensive literature survey was done aiming to compare and compile cancer tests makers required in diagnosis of diseases. Results: Cytoplasmic Proteins, Cell Surface Antigens, Oncofetal Antigens, Receptors, Oncogenes and their metabolic products, Acute-Phase Proteins, Enzymes, Hormones or Tumor associated antigens such as Carcino-Embryonic Antigen (CEA) and Alpha Feto Protein (AFP) are makers for routine analysis whereas several studies have confirmed and consolidated the usefulness of markers such as AFP:
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.